| GV | gastric volume; gas ventilation; gentian violet; germinal vesicle; granulosis virus; griseoviridan; Gross virus |
|---|---|
| GVA | general visceral afferent [nerve] |
| GVB | gelatin-Veronal buffer |
| GVBD | germinal vesicle breakdown |
| GVE | general visceral efferent [nerve] |
| GVF | good visual fields |
| GVG | gamma-vinyl-gamma-aminobutyric acid |
| GVH, GvH | graft-versus-host |
| GVHD | Graft-Versus-Host Disease; 식대주 질환 |
| GVHD, GvHD | graft-versus-host disease |
| GV | Gas ventilation |
|---|---|
| GV | Gentian Violet |
| GV | Germinal vesicle |
| GV | Growth velocity |
| GVB | Germinal vesicle breakdown |
| GVBD | Germinal Vesicle Breakdown |
| GVD | Graft vascular disease |
| GVEC | Glomerular visceral epithelial cell |
| GVG | Gamma vinyl GABA |
| GvH | Graft versus Host |
| GVH | <haematology> A common and serious, complication of bone marrow transplantation where there is a reaction of donated bone marrow against a patient's own tissue. When donor lymphocytes or a graft containing lymphocytes that are immunologically competent are given to a patient that has low immunological competence, an incompatibility reaction can result. This is due to antibodies from the donor against antigens in the host. This is due to mismatch of MHC Class I antigens and can produce lymphocyte clones that will react by a variety of processes against the host and cause damage. The clinical condition can be fatal and is due to the donor's immune cells recognising the host cells as foreign. The clinical entity characterised by anorexia, diarrhoea, loss of hair, leukopenia, thrombocytopenia, growth retardation, and eventual death brought about by the graft-versus-host reaction. It can occur in either chronic or acute forms and is treatable by immunosuppressive drugs. Seen most commonly following bone marrow transplantation, acute disease is seen after 5-40 days and chronic disease weeks to months after transplantation, affecting, principally, the gastrointestinal tract, liver, and skin. Radiological appearances of the gastrointestinal tract include; thickened wall, mucosal folds thickened or effaced, increased secretions most likely to be rapid transit of GI tract, mass most likely to be focal oedema, fibrosis, hallmark: diffuse, uniform thickening of small bowel. Synonym: GVH disease. Acronym: GVHD (20 Sep 2002) Previous: graft enhancement, immunologic, grafter, grafting, graft occlusion, graft rejection, graft survivalNext: graft-versus-host reaction, graft-versus-host responseGVH -->graft-versus-host reaction graft-versus-host disease Previous: graft occlusion, graft rejection, graft survival, graft-versus-host diseaseNext: graft-versus-host response, Graham-Cole test, GrahamellaGVH -->graft-versus-host response graft-versus-host disease |
|---|---|
| GVH disease | <haematology> A common and serious, complication of bone marrow transplantation where there is a reaction of donated bone marrow against a patient's own tissue. When donor lymphocytes or a graft containing lymphocytes that are immunologically competent are given to a patient that has low immunological competence, an incompatibility reaction can result. This is due to antibodies from the donor against antigens in the host. This is due to mismatch of MHC Class I antigens and can produce lymphocyte clones that will react by a variety of processes against the host and cause damage. The clinical condition can be fatal and is due to the donor's immune cells recognising the host cells as foreign. The clinical entity characterised by anorexia, diarrhoea, loss of hair, leukopenia, thrombocytopenia, growth retardation, and eventual death brought about by the graft-versus-host reaction. It can occur in either chronic or acute forms and is treatable by immunosuppressive drugs. Seen most commonly following bone marrow transplantation, acute disease is seen after 5-40 days and chronic disease weeks to months after transplantation, affecting, principally, the gastrointestinal tract, liver, and skin. Radiological appearances of the gastrointestinal tract include; thickened wall, mucosal folds thickened or effaced, increased secretions most likely to be rapid transit of GI tract, mass most likely to be focal oedema, fibrosis, hallmark: diffuse, uniform thickening of small bowel. Synonym: GVH disease. Acronym: GVHD (20 Sep 2002) |
| GVHD | <haematology> A common and serious, complication of bone marrow transplantation where there is a reaction of donated bone marrow against a patient's own tissue. When donor lymphocytes or a graft containing lymphocytes that are immunologically competent are given to a patient that has low immunological competence, an incompatibility reaction can result. This is due to antibodies from the donor against antigens in the host. This is due to mismatch of MHC Class I antigens and can produce lymphocyte clones that will react by a variety of processes against the host and cause damage. The clinical condition can be fatal and is due to the donor's immune cells recognising the host cells as foreign. The clinical entity characterised by anorexia, diarrhoea, loss of hair, leukopenia, thrombocytopenia, growth retardation, and eventual death brought about by the graft-versus-host reaction. It can occur in either chronic or acute forms and is treatable by immunosuppressive drugs. Seen most commonly following bone marrow transplantation, acute disease is seen after 5-40 days and chronic disease weeks to months after transplantation, affecting, principally, the gastrointestinal tract, liver, and skin. Radiological appearances of the gastrointestinal tract include; thickened wall, mucosal folds thickened or effaced, increased secretions most likely to be rapid transit of GI tract, mass most likely to be focal oedema, fibrosis, hallmark: diffuse, uniform thickening of small bowel. Synonym: GVH disease. Acronym: GVHD (20 Sep 2002) |
| GVHR | graft-versus-host disease |
| GVHD |
Graft-versus-host disease is a common complication of allogeneic bone marrow transplantation. After bone marrow transplantation, T cells present in the graft, either as contaminants or intentionally introduced into the host, attack the tissues of the transplant recipient. Graft-versus-host disease can occur even when HLA-identical sibling are the donors. ...
출처: en.wikipedia.org/wiki/GVHD
|
|---|---|
| GVH |
A reaction that occurs when lymphocytes of a different MHC class are introduced into a host, resulting in the reaction of the lymphocytes against the host.
출처: www.genpromag.com/Glossary~LETTER~G.html
|
| GVHD |
a condition in which transplanted immune tissue (eg, bone marrow cells) attack the tissues of the new host's body.
출처: www.aegis.com/ni/topics/glossary/g.asp
|
| GVHD |
Graft-versus-host disease. A reaction of donated bone marrow or peripheral stem cells against a person's tissue.
출처: www.seniormag.com/conditions/cancer/cancerglossary...
|
| GVHD |
After bone marrow transplantation, immune cells in the donated (grafted) material may identify the patient's (host) tissue as foreign and try to destroy them. This can be a serious problem, and drugs are available to combat it. However, in some cases, a GVH reaction actually helps to control the cancer.
출처: www.clevelandclinic.org/cancer/general/glossary/g....
|
제품명 |
판매사 |
보험코드 | 성분/함량 | 구분/보험급여 |
|---|
제품명 |
판매사 |
보험코드 | 성분/함량 | 구분/보험급여 |
|---|